Ofichem brings all brands under single trading name
pharmafile | April 23, 2026 | News story | | Ofichem
Ofichem has brought all its brands under its trading name to provide its customers a single integrated offering.
The company said its branded products had increased in number as it had grown and developed its activities in areas including drug substance, drug product, and sourcing and distribution.
However, it added that the trend within the pharmaceutical and biotech sector has been towards fewer, more integrated partners that can support them “across the life cycle of their drug”.
“Over time, we’ve built a business with real depth across API, drug substance, drug product and supply,” said CEO Weite Oldenziel.
“What has been less visible is how those capabilities come together. Combining all brands under the Ofichem umbrella makes that clear as we continue to support our customers in a more connected and consistent way.”
The impending change will apply to brands including Ofichem, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala and Avivia. From April, all business units are now operating under the Ofichem trading name.
“This is not a change to what we do, but to how clearly we present it,” assured Oldenziel, who said the objective was to provide better access to Ofichem’s offering spanning early-stage support to commercial supply.
“Our customers can expect the same reliability and flexibility, now with greater visibility of our comprehensive support as we strive to give every medicine the best chance of fulfilling its potential,” added the CEO.
The strategy is aimed at strengthening the family-owned pharmaceutical supplier’s role as a European-based CDMO partner, combining regulatory expertise, supply chain reliability and closer collaboration in a market that it says is “increasingly focused on security, transparency and control”.
